Cargando…

Podocytopathy in patients with monoclonal gammopathy: three patients and literature review

BACKGROUND: Renal manifestations of monoclonal gammopathies are of increasing interest among nephrologists. Typical manifestations include light chain cast nephropathy, amyloidosis or renal damage mediated by monoclonal immunoglobulin deposition. Podocytopathies in the setting of an underlying monoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribas, Andrés, Puche, Adrián, Gimeno, Javier, Sans, Laia, Barrios, Clara, Márquez, Eva, Naranjo, Dolores, Lloveras, Belén, Lop, Joan, Ramos, Natàlia, Soler, Maria José, Gabaldon, Alejandra, Crespo, Marta, Rodríguez, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862048/
https://www.ncbi.nlm.nih.gov/pubmed/35211301
http://dx.doi.org/10.1093/ckj/sfab176
_version_ 1784654986904338432
author Ribas, Andrés
Puche, Adrián
Gimeno, Javier
Sans, Laia
Barrios, Clara
Márquez, Eva
Naranjo, Dolores
Lloveras, Belén
Lop, Joan
Ramos, Natàlia
Soler, Maria José
Gabaldon, Alejandra
Crespo, Marta
Rodríguez, Eva
author_facet Ribas, Andrés
Puche, Adrián
Gimeno, Javier
Sans, Laia
Barrios, Clara
Márquez, Eva
Naranjo, Dolores
Lloveras, Belén
Lop, Joan
Ramos, Natàlia
Soler, Maria José
Gabaldon, Alejandra
Crespo, Marta
Rodríguez, Eva
author_sort Ribas, Andrés
collection PubMed
description BACKGROUND: Renal manifestations of monoclonal gammopathies are of increasing interest among nephrologists. Typical manifestations include light chain cast nephropathy, amyloidosis or renal damage mediated by monoclonal immunoglobulin deposition. Podocytopathies in the setting of an underlying monoclonal gammopathy constitute a rare manifestation of these diseases and, although being described in the literature, remain a challenge since most data derive from case reports. METHODS: A retrospective review of the clinical data of Hospital del Mar and Hospital Vall d’Hebron was performed to identify patients with minimal change disease (MCD) or focal and segmental glomerulosclerosis (FSGS) in the setting of neoplasms that produce monoclonal (M) protein. Additionally, a literature review on this topic was performed. This study aims to describe the clinical characteristics and outcomes of these patients. RESULTS: Three patients were identified to have podocytopathy and monoclonal gammopathy between the years 2013 and 2020. All three were males and  >65 years of age. Two patients were diagnosed with MCD and one patient was diagnosed with FSGS. All patients underwent a kidney biopsy and light and electron microscopic studies were performed. The underlying causes of monoclonal gammopathy were multiple myeloma in two cases and Waldeström macroglobulinemia in one case. Two patients developed nephrotic syndrome during the follow-up. All patients were under active hematological treatment. One patient presented a complete remission of proteinuria whereas the other two presented a partial remission. CONCLUSIONS: Podocytopathies may infrequently be found in patients with monoclonal gammopathies. Patients with overt glomerular proteinuria and hematological disorders with M protein should undergo a kidney biopsy for prompt diagnosis and to specify a prognosis. In addition, further study on this matter must be done to understand the pathophysiology and treat these patients appropriately.
format Online
Article
Text
id pubmed-8862048
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-88620482022-02-23 Podocytopathy in patients with monoclonal gammopathy: three patients and literature review Ribas, Andrés Puche, Adrián Gimeno, Javier Sans, Laia Barrios, Clara Márquez, Eva Naranjo, Dolores Lloveras, Belén Lop, Joan Ramos, Natàlia Soler, Maria José Gabaldon, Alejandra Crespo, Marta Rodríguez, Eva Clin Kidney J CKJ Review BACKGROUND: Renal manifestations of monoclonal gammopathies are of increasing interest among nephrologists. Typical manifestations include light chain cast nephropathy, amyloidosis or renal damage mediated by monoclonal immunoglobulin deposition. Podocytopathies in the setting of an underlying monoclonal gammopathy constitute a rare manifestation of these diseases and, although being described in the literature, remain a challenge since most data derive from case reports. METHODS: A retrospective review of the clinical data of Hospital del Mar and Hospital Vall d’Hebron was performed to identify patients with minimal change disease (MCD) or focal and segmental glomerulosclerosis (FSGS) in the setting of neoplasms that produce monoclonal (M) protein. Additionally, a literature review on this topic was performed. This study aims to describe the clinical characteristics and outcomes of these patients. RESULTS: Three patients were identified to have podocytopathy and monoclonal gammopathy between the years 2013 and 2020. All three were males and  >65 years of age. Two patients were diagnosed with MCD and one patient was diagnosed with FSGS. All patients underwent a kidney biopsy and light and electron microscopic studies were performed. The underlying causes of monoclonal gammopathy were multiple myeloma in two cases and Waldeström macroglobulinemia in one case. Two patients developed nephrotic syndrome during the follow-up. All patients were under active hematological treatment. One patient presented a complete remission of proteinuria whereas the other two presented a partial remission. CONCLUSIONS: Podocytopathies may infrequently be found in patients with monoclonal gammopathies. Patients with overt glomerular proteinuria and hematological disorders with M protein should undergo a kidney biopsy for prompt diagnosis and to specify a prognosis. In addition, further study on this matter must be done to understand the pathophysiology and treat these patients appropriately. Oxford University Press 2021-09-28 /pmc/articles/PMC8862048/ /pubmed/35211301 http://dx.doi.org/10.1093/ckj/sfab176 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the ERA. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle CKJ Review
Ribas, Andrés
Puche, Adrián
Gimeno, Javier
Sans, Laia
Barrios, Clara
Márquez, Eva
Naranjo, Dolores
Lloveras, Belén
Lop, Joan
Ramos, Natàlia
Soler, Maria José
Gabaldon, Alejandra
Crespo, Marta
Rodríguez, Eva
Podocytopathy in patients with monoclonal gammopathy: three patients and literature review
title Podocytopathy in patients with monoclonal gammopathy: three patients and literature review
title_full Podocytopathy in patients with monoclonal gammopathy: three patients and literature review
title_fullStr Podocytopathy in patients with monoclonal gammopathy: three patients and literature review
title_full_unstemmed Podocytopathy in patients with monoclonal gammopathy: three patients and literature review
title_short Podocytopathy in patients with monoclonal gammopathy: three patients and literature review
title_sort podocytopathy in patients with monoclonal gammopathy: three patients and literature review
topic CKJ Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862048/
https://www.ncbi.nlm.nih.gov/pubmed/35211301
http://dx.doi.org/10.1093/ckj/sfab176
work_keys_str_mv AT ribasandres podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT pucheadrian podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT gimenojavier podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT sanslaia podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT barriosclara podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT marquezeva podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT naranjodolores podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT lloverasbelen podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT lopjoan podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT ramosnatalia podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT solermariajose podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT gabaldonalejandra podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT crespomarta podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview
AT rodriguezeva podocytopathyinpatientswithmonoclonalgammopathythreepatientsandliteraturereview